Key Aspects of Magnesium in Clinical Practice
Magnesium is primarily an intracellular ion, with deficiency causing hyperreflexia rather than hyporeflexia, and is predominantly excreted through the kidneys rather than the stool.
Magnesium as an Intracellular Ion
- Magnesium is the second most abundant intracellular cation in the human body 1, 2
- While only about 1% of total body magnesium is found in the blood, more than 99% is stored intracellularly (primarily in bone, soft tissue, and muscle) 3
- The concentration of magnesium in red blood cells (around 2.5 mmol/L) provides a better indicator of tissue magnesium content than serum levels 4
- Magnesium plays a critical role in:
Magnesium Deficiency and Clinical Manifestations
Magnesium deficiency typically presents with neuromuscular hyperexcitability (not hyporeflexia) 5, 6
Other clinical manifestations include:
- Cardiac arrhythmias and increased risk of sudden cardiac death 3
- Hypocalcemia due to both deficient PTH release and peripheral resistance to PTH 4
- Hypokalemia that may be refractory to potassium supplementation 6
- Increased sensitivity to digoxin 1, 6
- Abdominal cramps, impaired healing, fatigue, and bone pain 3
Risk factors for magnesium deficiency include:
Magnesium Excretion
- Approximately one-third of magnesium intake is excreted in the urine, not the stool 4
- The kidney is the major regulator of magnesium homeostasis 7
- Only 5-15% of filtered magnesium is reabsorbed by the kidneys 4
- In conditions of magnesium deprivation, both the kidney and small intestine increase their fractional absorption of magnesium 6
- When magnesium depletion continues, bone stores contribute by exchanging part of their content with extracellular fluid 6
Diagnostic Considerations
- Serum magnesium levels may be normal despite intracellular magnesium depletion 6
- A low serum magnesium level usually indicates significant magnesium deficiency 6
- Normal range for magnesium in premature and term newborns during the first two weeks of life is 0.7-1.5 mmol/L 4
- The magnesium tolerance test may be more indicative of low magnesium states than serum concentration 5
Treatment Approaches
- For life-threatening manifestations: IV magnesium (1-2g of MgSO4) 3
- For less critical situations: Oral magnesium supplementation 3
- Magnesium therapy should be monitored with follow-up serum levels 1-2 weeks after starting supplementation 3
- Target serum magnesium level should be >0.6 mmol/L 3
Clinical Pitfalls to Avoid
- Relying solely on serum magnesium levels to assess total body magnesium status 3, 6
- Failing to consider magnesium deficiency in patients with refractory hypokalemia or hypocalcemia 6
- Overlooking magnesium status in critically ill patients, especially those in shock states 4, 1
- Administering magnesium to patients with known or suspected hypermagnesemia 3
- Neglecting to monitor magnesium levels in patients on diuretics, PPIs, or with polypharmacy 3